Skip to content

Biofrontera AG

CIK 0001712641

← back to feed
Revenue (TTM)
€30.35M
−2.9% YoY FY Dec 2020
Net Income (TTM)
−€13.02M
−77.0% YoY FY Dec 2020
EPS Diluted (TTM)
—
FY Dec 2020
Gross Margin
88.3%
FY Dec 2020
Operating Margin
-25.1%
FY Dec 2020
Net Margin
-42.9%
FY Dec 2020
Free Cash Flow (TTM)
—
FY Dec 2020
Cash
€16.55M
FY Dec 2020
Total Debt
—
FY Dec 2020
Shares Outstanding
47.75M sh
FY Dec 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings